OBJECTIVES: Orofacial clefts are common birth defects that often require multiple surgeries and medical treatments during childhood. We used healthcare insurance claims data to estimate health-care expenditures for infants and children < or = 10 years of age with an orofacial cleft. METHODS: The data were derived from the 2000-2004 MarketScan Commercial Claims and Encounters databases, which include person-specific information on health-care use, expenditures, and enrollment for approximately 50 large employers, health plans, and government and public organizations. Health insurance claims data from 821,619 children < or = 10 years of age enrolled in employer-sponsored plans during 2004 were analyzed. Expenditures for inpatient admissions, outpatient services, and prescription drug claims were calculated for children with and those without an orofacial cleft. RESULTS: The difference in annual mean costs (i.e., incremental costs) between children aged 0 through 10 years with an orofacial cleft and those without an orofacial cleft was $13,405. The mean and median costs for children < or = 10 years of age with an orofacial cleft were eight times higher than for children of the same age without an orofacial cleft. Mean costs for infants with a cleft and another major, unrelated defect were 25 times higher than those for an infant without a cleft, and five times higher than for infants with an isolated cleft. CONCLUSION: These findings document substantially elevated medical care costs for privately insured children with an orofacial cleft. Additional study of the economic burden associated with this condition should include a broader range of economic costs.
OBJECTIVES: Orofacial clefts are common birth defects that often require multiple surgeries and medical treatments during childhood. We used healthcare insurance claims data to estimate health-care expenditures for infants and children < or = 10 years of age with an orofacial cleft. METHODS: The data were derived from the 2000-2004 MarketScan Commercial Claims and Encounters databases, which include person-specific information on health-care use, expenditures, and enrollment for approximately 50 large employers, health plans, and government and public organizations. Health insurance claims data from 821,619 children < or = 10 years of age enrolled in employer-sponsored plans during 2004 were analyzed. Expenditures for inpatient admissions, outpatient services, and prescription drug claims were calculated for children with and those without an orofacial cleft. RESULTS: The difference in annual mean costs (i.e., incremental costs) between children aged 0 through 10 years with an orofacial cleft and those without an orofacial cleft was $13,405. The mean and median costs for children < or = 10 years of age with an orofacial cleft were eight times higher than for children of the same age without an orofacial cleft. Mean costs for infants with a cleft and another major, unrelated defect were 25 times higher than those for an infant without a cleft, and five times higher than for infants with an isolated cleft. CONCLUSION: These findings document substantially elevated medical care costs for privately insured children with an orofacial cleft. Additional study of the economic burden associated with this condition should include a broader range of economic costs.
Authors: Sonja A Rasmussen; Richard S Olney; Lewis B Holmes; Angela E Lin; Kim M Keppler-Noreuil; Cynthia A Moore Journal: Birth Defects Res A Clin Mol Teratol Date: 2003-03
Authors: Sheree L Boulet; Noelle-Angelique Molinari; Scott D Grosse; Margaret A Honein; Adolfo Correa-Villaseñor Journal: J Pediatr Date: 2008-04-23 Impact factor: 4.406
Authors: Cara T Mai; Cynthia H Cassell; Robert E Meyer; Jennifer Isenburg; Mark A Canfield; Russel Rickard; Richard S Olney; Erin B Stallings; Meredith Beck; S Shahrukh Hashmi; Sook Ja Cho; Russell S Kirby Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-11-14
Authors: Hilda Razzaghi; April Dawson; Scott D Grosse; Alexander C Allori; Russell S Kirby; Richard S Olney; Jane Correia; Cynthia H Cassell Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-02
Authors: Ryan Mayhew; June M McKoy; Thanh Ha Luu; Isaac Lopez; Melissa Frick; Charles L Bennett Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981
Authors: Nalin Payakachat; J Mick Tilford; Werner Bf Brouwer; N Job van Exel; Scott D Grosse Journal: Qual Life Res Date: 2011-02-24 Impact factor: 4.147
Authors: Samar Sheriff; Hassan J Zawahrah; Lenisa V Chang; Sonay Beyatli; Haithem M Elhadi Babiker; Ashton L Roach; Natalyia Biskup; John A van Aalst Journal: World J Surg Date: 2018-05 Impact factor: 3.352
Authors: George Wehby; Astanand Jugessur; Jeffrey C Murray; Lina Moreno; Allen Wilcox; Rolv T Lie Journal: Health Serv Outcomes Res Methodol Date: 2011-07-01